1h Free Analyst Time
The brain tumor diagnostics market is forecasted to grow by USD 152.9 million during 2023-2028, accelerating at a CAGR of 3.4% during the forecast period. The report on the brain tumor diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of brain cancer, increasing prevalence of neurological disorders, and growing importance of tele-imaging.
The brain tumor diagnostics market is segmented as below:
By Type
- Imaging test
- Biopsy
- Molecular testing
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the brain tumor diagnostics market covers the following areas:
- Brain Tumor Diagnostics Market sizing
- Brain Tumor Diagnostics Market forecast
- Brain Tumor Diagnostics Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global brain tumor diagnostics market: Amgen Inc., AstraZeneca Plc, Biocept Inc., Canon Inc., FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Hitachi Ltd., Hologic Inc., Koninklijke Philips N.V., MDXHEALTH SA, Merck and Co. Inc., NantOmics, Neusoft Medical Systems Co. Ltd., Pfizer Inc., Shimadzu Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in research and development and advances in technology."
According to the report, one of the major drivers for this market is the increasing prevalence of brain cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- AstraZeneca Plc
- Biocept Inc.
- Canon Inc.
- FUJIFILM Holdings Corporation
- GE Healthcare Technologies Inc.
- Hitachi Ltd.
- Hologic Inc.
- Koninklijke Philips N.V.
- MDXHEALTH SA
- Merck and Co. Inc.
- NantOmics
- Neusoft Medical Systems Co. Ltd.
- Pfizer Inc.
- Shimadzu Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
